CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Total Long-Term Debt
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Total Long-Term Debt of $1.61 billion as of 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Balance Sheet › Liabilities › Debt › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2019-02-13
- 2018-12-29: Long-term Debt $1.61B.
- 2018-09-29: Long-term Debt $1.63B.
- 2018-06-30: Long-term Debt $1.77B.
- 2018-03-31: Long-term Debt $1.10B.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2018-12-29 | $1.61B 10-K · filed 2019-02-13 | |
| 2018-09-29 | $1.63B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.77B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.10B 10-Q · filed 2018-05-10 | |
| 2017-12-30 | $1.09B 10-K · filed 2019-02-13 | |
| 2017-09-30 | $1.13B 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $1.09B 10-Q · filed 2017-08-09 | |
| 2017-04-01 | $1.14B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.18B 10-K · filed 2018-02-13 | |
| 2016-09-24 | $1.21B 10-Q · filed 2016-11-02 | |
| 2016-06-25 | $1.30B 10-Q · filed 2016-08-03 | |
| 2016-03-26 | $810.64M 10-Q · filed 2016-05-04 | |
| 2015-12-26 | $814.24M 10-K · filed 2017-02-14 | |
| 2015-09-26 | $802.66M 10-Q · filed 2015-11-04 | |
| 2015-06-27 | $720.22M 10-Q · filed 2015-07-30 | |
| 2015-03-28 | $760.14M 10-Q · filed 2015-04-30 | |
| 2014-12-27 | $716.63M 10-K · filed 2016-02-12 | $753.75M 10-K · filed 2015-02-17 |
| 2014-09-27 | $769.64M 10-Q · filed 2014-10-30 | |
| 2014-06-28 | $802.80M 10-Q · filed 2014-08-07 | |
| 2014-03-29 | $640.09M 10-Q · filed 2014-04-30 | |
| 2013-12-28 | $663.05M 10-K · filed 2015-02-17 | |
| 2013-09-28 | $639.74M 10-Q · filed 2013-10-30 | |
| 2013-06-29 | $635.23M 10-Q · filed 2013-07-31 | |
| 2013-03-30 | $648.18M 10-Q · filed 2013-05-08 | |
| 2012-12-29 | $666.45M 10-K · filed 2014-02-25 | |
| 2012-09-29 | $668.73M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $686.20M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $704.28M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $717.90M 10-K · filed 2013-02-27 | |
| 2011-09-24 | $740.27M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $789.34M 10-Q · filed 2011-08-03 | |
| 2010-12-25 | $700.75M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |